Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IFNW1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TINF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNT5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDIA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPINK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEDD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00527 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
RBBP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSP90B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SS18L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIPH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on